L03RD1
Sponsors
Celltrion
Conditions
Type 2 Diabetes Mellitus (T2DM)
Phase 1
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers
CompletedNCT07158346
Start: 2025-08-18End: 2025-10-23Updated: 2025-11-21
Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
CompletedNCT07533539
Start: 2026-05-09End: 2026-06-16Updated: 2026-07-28